Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,803 | -2,982 | -8,461 | -5,314 | -3,260 |
| Depreciation Amortization | 167 | 82 | 300 | 218 | 134 |
| Accounts receivable | -769 | -118 | -649 | -803 | -535 |
| Other Working Capital | -1,113 | 308 | -852 | -1,841 | -764 |
| Other Operating Activity | 5,021 | 505 | 3,201 | 1,689 | 557 |
| Operating Cash Flow | $-5,497 | $-2,204 | $-6,461 | $-6,051 | $-3,868 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -469 | -243 | -991 | -580 | -230 |
| Purchase Sale Intangibles | -452 | -229 | -687 | -516 | -327 |
| Other Investing Activity | -452 | -229 | -687 | -516 | -327 |
| Investing Cash Flow | $-921 | $-472 | $-1,678 | $-1,096 | $-557 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 667 | 667 | 5,000 | 5,000 | 5,000 |
| Debt Repayment | -667 | -667 | N/A | N/A | N/A |
| Common Stock Issued | 2,667 | 544 | 1,445 | 442 | 207 |
| Other Financing Activity | 11,755 | 5,899 | 13,678 | 11,774 | 10,319 |
| Financing Cash Flow | $14,422 | $6,443 | $20,123 | $17,216 | $15,526 |
| Exchange Rate Effect | -44 | 1 | 92 | 87 | 56 |
| Beginning Cash Position | 17,322 | 17,322 | 5,245 | 5,245 | 5,245 |
| End Cash Position | 25,283 | 21,090 | 17,322 | 15,400 | 16,402 |
| Net Cash Flow | $7,961 | $3,768 | $12,077 | $10,155 | $11,157 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,497 | -2,204 | -6,461 | -6,051 | -3,868 |
| Capital Expenditure | -469 | -243 | -991 | -580 | -230 |
| Free Cash Flow | -5,965 | -2,447 | -7,451 | -6,631 | -4,098 |